Request Demo
Last update 08 Mar 2025
Santen Pharmaceutical (China) Co. Ltd.
Last update 08 Mar 2025
Overview
Tags
Eye Diseases
Immune System Diseases
Small molecule drug
Polymer
Synthetic peptide
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20243528
一项评估DE-117B滴眼液在中国原发性开角型青光眼或高眼压症受试者中的有效性和安全性并包括一项单臂、开放性、单剂量多次给药PK研究部分和一项含长期随访期的，随机、评估者设盲、阳性药物对照、平行组、多中心、桥接研究部分的III期研究
[Translation] A Phase III study to evaluate the efficacy and safety of DE-117B eye drops in Chinese subjects with primary open-angle glaucoma or ocular hypertension, including a single-arm, open-label, single-dose multiple-dose PK study part and a randomized, assessor-blinded, active drug-controlled, parallel-group, multicenter, bridging study part with a long-term follow-up period
CTR20243263
一项评价STN1013800滴眼液用于治疗中国获得性上睑下垂患者的有效性和安全性的多中心、随机、双盲、安慰剂对照、平行分组、III期研究
[Translation] A multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase III study to evaluate the efficacy and safety of STN1013800 eye drops in the treatment of acquired ptosis in Chinese patients
CTR20234212
0.1%STN1011403滴眼液治疗过敏性结膜炎的多中心随机评价者盲态阳性对照试验
[Translation] A multicenter randomized evaluator-blind positive controlled trial of 0.1% STN1011403 eye drops in the treatment of allergic conjunctivitis
100 Clinical Results associated with Santen Pharmaceutical (China) Co. Ltd.
Login to view more data
Login to view more data
Iyakuhin Iryo Kiki Regyuratori Saiensu
Manufacturing environments and facilities of sterile pharmaceutical products blow-fill-seal
Author: Hinomoto, Tsutomu
A review discussing characteristics and management of blow-fill-seal (BFS) technol. for sterile packaging of pharmaceuticals is provided.
100 Deals associated with Santen Pharmaceutical (China) Co. Ltd.
Login to view more data
100 Translational Medicine associated with Santen Pharmaceutical (China) Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 01 Apr 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3
1
1
NDA/BLA
Approved
2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free